Although proteases related to the interleukin 1␤-converting enzyme (ICE) are known to be essential for apoptotic execution, the number of enzymes involved, their substrate specificities, and their specific roles in the characteristic biochemical and morphological changes of apoptosis are currently unknown. These questions were addressed using cloned recombinant ICE-related proteases (IRPs) and a cellfree model system for apoptosis (S͞M extracts). First, we compared the substrate specificities of two recombinant human IRPs, CPP32 and Mch2␣. Both enzymes cleaved poly-(ADP-ribose) polymerase, albeit with different efficiencies. Mch2␣ also cleaved recombinant and nuclear lamin A at a conserved VEIDsNG sequence located in the middle of the coiled-coil rod domain, producing a fragment that was indistinguishable from the lamin A fragment observed in S͞M extracts and in apoptotic cells. In contrast, CPP32 did not cleave lamin A. The cleavage of lamin A by Mch2␣ and by S͞M extracts was inhibited by millimolar concentrations of Zn 2؉ , which had a minimal effect on cleavage of poly(ADP-ribose) polymerase by CPP32 and by S͞M extracts. We also found that N-(acetyltyrosinylvalinyl-N -biotinyllysyl)aspartic acid [(2, 6-dimethylbenzoyl)oxy]methyl ketone, which derivatizes the larger subunit of active ICE, can affinity label up to five active IRPs in S͞M extracts. Together, these observations indicate that the processing of nuclear proteins in apoptosis involves multiple IRPs having distinct preferences for their apoptosisassociated substrates.
A key question in cell death research is whether the apoptotic cascade is driven by the action of a single interleukin 1␤-converting enzyme (ICE)-related protease (IRP) (1) (2) (3) (4) (5) (6) (7) or by multiple IRPs acting in concert (8) . In the nematode Caenorhabditis elegans, a single IRP is required for all developmental cell deaths (1, 9) . In contrast, cDNA cloning experiments show that at least seven IRP mRNAs are expressed in a single human cell type (4, 7, 10, 11) , raising the possibility that multiple IRPs might be required for completion of apoptosis in vertebrates. The individual roles of these multiple IRPs during apoptosis are currently unclear.
To begin to address this question, we have compared proteolytic cleavage of two apoptotic substrates by cloned IRPs expressed in Escherichia coli and by cell-free extracts (named S͞M extracts, prepared from chicken DU249 hepatoma cells committed to apoptosis by an S-phase aphidocolin block and subsequently collected in M phase) (12, 13) . Exogenous nuclei incubated in S͞M extracts recapitulate nuclear apoptotic events, including endonucleolytic cleavage of DNA, chromatin condensation, and fragmentation of the nucleus (12) . Incubation of nuclei or purified poly(ADP-ribose) polymerase (PARP) in S͞M extracts results in rapid, quantitative cleavage of the PARP to a 85-kDa fragment indistinguishable from that observed in a wide variety of apoptotic cells (13) (14) (15) . This cleavage occurs at a conserved DEVDsG sequence and is mediated by an enzyme with substrate recognition properties and inhibitor sensitivity similar to ICE. We termed this proteolytic activity prICE [protease(s) resembling ICE (13) ]. Subsequent investigations have shown that the cloned human IRPs CPP32, Mch2␣, and Mch3␣ as well as the C. elegans IRP CED-3 all cleave PARP (5, 7, 11, 16, 17) . ICE itself can also cleave a PARP subfragment when added in considerable excess (18) ; however, at near physiological levels, it does not cleave full-length native PARP (5, 13) .
Although PARP was the first apoptosis-specific IRP substrate to be identified, the physiological significance of PARP cleavage in apoptosis is presently unknown (for review, see ref. 15 ). In contrast, cleavage of the nuclear lamins is a proteolytic event that appears to be required for completion of nuclear reorganization during apoptosis. Lamin A is cleaved in S͞M extracts (8) to fragments that are indistinguishable from those produced in cells undergoing apoptosis (8, (19) (20) (21) . The inhibitor profile of the lamin protease suggests that lamin cleavage depends upon the activity of an IRP distinct from the PARPcleaving IRP (8) . Inhibition of the lamin protease by Tos-Lys-CH 2 Cl (TLCK) (8) or the serpin-like IRP inhibitor CrmA͞ SPI-2 (A.T., P.-Y. Musy, G.G.P., R. W. Moyer, and W.C.E., unpublished work) abolishes nuclear fragmentation in vitro. This has led to the speculation that activity of the lamin protease may be a prerequisite for apoptotic nuclear disassembly (8) .
Despite these advances in our understanding of IRP activity during apoptosis, it remains to be determined whether lamin cleavage is directly catalyzed by an IRP and whether multiple
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked ''advertisement'' in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Abbreviations: ICE, interleukin 1␤-converting enzyme; IRP, ICErelated protease; PARP, poly(ADP-ribose) polymerase; S͞M extract, extract from cells committed to apoptosis by an S-phase aphidocolin block and subsequently collected in M phase; prICE, protease(s) resembling ICE; DMSO, dimethyl sulfoxide; YVAD-cmk, Tyr-ValAla-Asp-CH2Cl. ‡ 
MATERIALS AND METHODS
Assay of Protease Activity in E. coli Lysates Containing Recombinant Human IRPs. Lysates from E. coli DH5␣ expressing CPP32␣ and Mch2␣ were prepared as described (7), except that the E. coli lysis buffer was supplemented with chymostatin, leupeptin, antipain, pepstatin, phenylmethylsulfonyl fluoride, and aprotinin. Purified recombinant human lamin A (8), purified bovine PARP (13) , and nuclei isolated from HeLa S3 cells (12) were incubated with the E. coli lysates at 37°C; substrate cleavage was analyzed by immunoblotting as described (8, 13) . To control for the effects of endogenous E. coli proteases, the substrates were also incubated with lysates from E. coli that were not transformed with plasmids or with lysates from E. coli expressing Mch2␤, a catalytically inactive truncated version of Mch2␣ (7) . Autoradiographic films were scanned using the COLLAGE software (Fotodyne, New Berlin, WI) so that cleavage could be quantitated from the intensity of the signals of uncleaved and cleaved substrates.
Mapping the Lamin A Cleavage Site. Lamin A (amino acids 1-463) tagged with (His) 6 at its C terminus was purified using Ni 2ϩ -agarose resin (Novagen) according to the manufacturer's instructions. After 200 pmol of this substrate was incubated with 1.25 mg of E. coli lysate expressing Mch2␣ for 120 min, the cleaved C-terminal fragment was repurified on Ni 2ϩ -agarose, subjected to SDS͞PAGE, transferred to polyvinylidene dif luoride (PVDF) membrane (22) , and microsequenced. The sequence revealed multiple amino acids at each position, but after subtraction of the sequences of two bacterial proteins that also bound the metal column [E. coli 30-kDa protein (23) and E. coli curved DNA binding protein (24) ; both are perfect 12͞12 matches], the remaining sequence consisted of N*K*REFESRL, a perfect match to positions 231-241 of human lamin A.
Direct Labeling of Active IRPs in S͞M Extracts. S͞M extracts were prepared from chicken DU249 cells as described (12) . N-(acetyltyrosinylvalinyl-N -biotinyllysyl)aspartic acid [(2,6-dimethylbenzoyl)oxy]methyl ketone (25) [here termed YV(bio)KD-aomk] was kindly provided by Nancy Thornberry (Merck), dissolved in dimethyl sulfoxide (DMSO) at 10 mM, and stored at Ϫ80°C. S͞M extracts were incubated with YV(bio)KD-aomk for 5 min at 37°C, subjected to SDS͞PAGE in 16% gels, transferred to nitrocellulose, probed with peroxidase-labeled streptavidin, and visualized by the Enhanced Chemiluminesence kit (Amersham).
Labeling and Quantitation of Active IRPs in E. coli Lysates. Lysates (150 g) from E. coli expressing CPP32␣ or Mch2␣ and purified recombinant ICE (1.2 ng) (13) were incubated with 10 M of YV(bio)KD-aomk for 5 min at 37°C and processed for detection of the bound biotin as described above for S͞M extracts. The bands corresponding to the larger subunit of active CPP32␣ (Ϸ17 kDa), Mch2␣ (Ϸ19 kDa), and ICE (Ϸ20 kDa) were scanned and their intensity was measured using the COLLAGE software. The quantity of active IRP giving a labeling intensity corresponding to that seen with 1 ng of purified recombinant ICE was defined as ''1 IRP unit.'' One milligram of E. coli lysate containing CPP32␣ and Mch2␣ had 24 and 19 IRP units of active enzymes, respectively. When defining the total number of IRP units in a given amount of S͞M extract, the labeling of all YV(bio)KD-aomk-labeled bands corresponding to prICE [1] [2] [3] [4] [5] was determined. When defining the number of PARP-cleaving IRP units in a given amount of S͞M extract, only the content of active prICE 1 was used, because this species appeared to have a much higher affinity for the PARP cleavage site peptide than did prICE [2] [3] [4] [5] .
RESULTS
Cleavage of Lamin A by Mch2␣, but Not by CPP32. To assess the possibility that lamins are cleaved by IRP(s) in apoptosis, we examined the ability of cloned human IRPs to cleave lamin A. E. coli lysates containing recombinant Mch2␣, an IRP resembling CED-3, cleaved purified recombinant human lamin A (Fig. 1a, lane 4) to generate a fragment that comigrated with a fragment produced in S͞M extracts (Fig. 1a, lane  3) . In control experiments, lysates from untransformed E. coli DH5␣ (Fig. 1a, lane 2) or from E. coli expressing the inactive Mch2 splice variant Mch2␤ (Fig. 1a, lane 5) failed to cleave lamin A. Lamin A cleavage by Mch2␣ was readily inhibited by the IRP inhibitor Tyr-Val-Ala-Asp-CH 2 Cl (YVAD-cmk) (Fig.  1c) , but not by a cocktail of other inhibitors that was routinely included in the E. coli lysis buffer. This mixture contained chymostatin, leupeptin, antipain, pepstatin, phenylmethylsulfonyl fluoride, and aprotinin. Mch2␣ also cleaved endogenous human lamin A in HeLa nuclei (Fig. 1b, lane 2) . Again, the lamin A fragment comigrated with a fragment observed in apoptosis in vitro (Fig. 1b, lane 4) and in vivo (8) .
Not all IRPs involved in apoptosis are active against the lamin substrate. CPP32, a second IRP homologous to CED-3, appears to be incapable of cleaving lamin A (Fig. 1 a, lane 6 , and b, lane 3). After normalization of the amounts of active enzymes in E. coli lysates (see Materials and Methods), the proteolytic activities of Mch2␣ and CPP32 against different substrates were compared. The rate of lamin A cleavage by Mch2␣ was roughly comparable with that of S͞M extracts, whereas CPP32 failed to cleave this substrate (Fig. 1d) . The converse was true for PARP cleavage. Initial rates of PARP cleavage by CPP32 and S͞M extract were essentially identical (Fig. 1e) . Although Mch2␣ does possess PARP cleavage activity (7), this is considerably lower than the activity of CPP32 against PARP (Fig. 1e) . These results revealed that Mch2␣ and CPP32 have distinct preferences for lamin A and PARP, respectively.
Lamin A Cleavage Site. Peptide sequencing of the Mch2␣ cleavage product from a purified recombinant human lamin A subfragment (see Materials and Methods) revealed that cleavage occurred at D 230 of lamin A (Fig. 2a) . Alignment of lamin A sequences available in the data bases revealed that this cleavage site, which lies in the midst of the ␣-helical rod domain, is well-conserved across species from mammals to Drosophila (Fig. 2a) .
We have used synthetic peptides to confirm that the endogenous lamin protease in S͞M extracts recognizes the Mch2␣ cleavage site on lamin A. We synthesized an 11-mer peptide corresponding to the lamin A cleavage site (RLVEIDNGKQR) and a mutant peptide containing alanine in place of aspartate (RLVEIANGKQR). The cleavage site peptide inhibited lamin A cleavage by S͞M extracts (Fig. 2b,  lane 3 ) and by Mch2␣ (data not shown), whereas the mutant peptide had no effect (Fig. 2b, lane 4) . The lamin A peptide did not affect PARP cleavage in S͞M extracts (Fig. 2b, lane 3) . This result strongly suggests that Mch2␣ and the endogenous lamin protease in S͞M extracts cleave lamin A at the same VEIDsNG bond. Moreover, these results demonstrated a requirement for aspartate at the P 1 position of the lamin cleavage site, a characteristic of IRPs (26) .
In a control experiment, we confirmed our previous finding that cleavage of PARP in the apoptotic extracts could be specifically inhibited by a peptide (GDEVDGIDEV) spanning 8396
Cell USA 93 (1996) the PARP cleavage site (13) . This peptide had no detectable effect on the efficiency of lamin A cleavage at concentrations where it substantially lowered the efficiency of PARP cleavage (Fig. 2b, lane 5) . PARP cleavage by CPP32 was inhibited by the PARP cleavage site D peptide (Fig. 2b, lane 9) but only poorly by the mutant A peptide (Fig. 2b, lane 10) . Together, these observations confirm that the endogenous lamin and PARP proteases in S͞M extracts have distinct substrate recognition properties similar to those of Mch2␣ and CPP32. Inhibition of Lamin A but Not PARP Cleavage by Zn 2؉ . Cleavage of purified recombinant human lamin A by Mch2␣ (Fig. 3a) and by S͞M extracts (Fig. 3b) was inhibited by Zn 2ϩ in a dose-dependent manner. Zn 2ϩ also blocks the cleavage of endogenous nuclear lamin A in HeLa nuclei induced by S͞M extracts (Fig. 3b) . Under these conditions, completion of morphological apoptosis was also blocked (12) .
In contrast, cleavage of purified bovine PARP catalyzed by both recombinant CPP32 (Fig. 3a) and S͞M extracts (Fig. 3b) was relatively insensitive to Zn 2ϩ . A similar result was obtained with endogenous nuclear human PARP (Fig. 3b) .
Multiple Active IRPs in S͞M Extracts. Our functional studies reveal that S͞M extracts contain at least two distinct IRPs with differing substrate preferences and differing inhibitor profiles (Figs. 2b and 3b) . To directly visualize these enzymes, we set out to establish whether YV(bio)KD-aomk, a probe that was developed to covalently derivatize the larger subunit of active ICE but not its inactive proenzyme (25) , would also directly label other IRPs. Control experiments (Fig.  4b) indicated that 10 M YV(bio)KD-aomk labels cloned human CPP32 and Mch2␣ in E. coli extracts, indicating that this reagent will react with the active sites of diverse IRPs in addition to ICE. When this same approach was applied to S͞M extracts, up to five polypeptides of Ϸ19.5, 19, 18.5, 17.8, and 17.6 kDa were reproducibly labeled after reaction with 100 M YV(bio)KD-aomk (Fig. 4a, lane 1) . All of these labeled species differed in mobility from the p20 subunit of purified human ICE (Fig. 4a, lanes 7 and 9) . In keeping with our earlier terminology, we have termed these bands prICE [1] [2] [3] [4] [5] . prICE [1] [2] [3] [4] [5] exhibit a distinct hierarchy of labeling by YV(bio)KD-aomk. prICE 4 is labeled at 0.1 M YV(bio)KD-aomk (Fig. 4a, lane  5) , prICE 1 and prICE 5 are labeled at 1 M (Fig. 4a, lane 4) , and prICE 2 and prICE 3 require 100 M for labeling (Fig. 4a,  lane 1) . This labeling hierarchy suggests that prICE 1-5 exhibit a hierarchy of affinities for YV(bio)KD-aomk.
Several control experiments indicate that the labeled species correspond to active IRPs. First, preincubation of S͞M extracts with 100 M YVAD-cmk, a broad spectrum inhibitor of IRPs at this concentration, abolished the labeling of all five bands (Fig. 4a, lane 2) . Second, no labeled polypeptides were detected in extracts from nonapoptotic cells (Fig. 4a, lane 8) , indicating that prICE [1] [2] [3] [4] [5] are active only in apoptotic cells. Third, labeling required the addition of YV(bio)KD-aomk (Fig. 4a, lane 6) , thereby ruling out the trivial explanation that the labeled species correspond to endogenous biotinylated proteins. Finally, the labeled species roughly comigrate with the large subunits of known human IRPs [17 kDa for CPP32 (4, 16); 19 kDa for Mch2␣ (7)]. No labeling was seen of species in the size range expected for IRP precursors . prICE 1 can be distinguished from prICE [2] [3] [4] [5] by its affinity for the PARP cleavage site peptide (13) . The addition of this peptide to S͞M extracts markedly diminished the labeling of prICE 1 whilst leaving the labeling of prICE 4 Proc. Natl. Acad. Sci. USA 93 (1996) unchanged (Fig. 4c, lane 2) . Under the conditions of this experiment, labeling of prICE 2 and prICE 3 was not readily observed. In a control experiment, the labeling of prICE 1 was not inhibited by the D f A mutant peptide (Fig. 4c, lane 3) , which does not inhibit PARP cleavage in S͞M extracts (13) . Together, these results indicate that prICE 1 has a greater affinity for the PARP cleavage sequence than prICE 4 and prICE 5 .
DISCUSSION
Accumulating evidence suggests that the cleavage of nuclear lamins is a universal event in apoptosis in vivo (8, (19) (20) (21) and in vitro (8) . Here, we have shown that the CED-3-related human IRP Mch2␣ cleaves lamin A. A second wellcharacterized CED-3-related human IRP, CPP32, did not cleave lamin A under conditions in which it readily cleaved PARP. Thus, CPP32 alone cannot mediate all of the proteolytic events essential for the apoptotic disintegration of nuclei (8) . Recombinant ICE was similarly inactive against lamin A (unpublished data). Peptide sequencing revealed that the cleavage by Mch2␣ occurs adjacent to a conserved asp residue in the ␣-helical rod domain of lamin A. This cleavage could potentially disrupt lamin-lamin interactions as well as interactions of lamins with other nuclear components such as matrix attachment regions on the DNA (27), the retinoblastoma gene product (28), the adenovirus E1B 19-kDa product (29) , and core histones (30) . The observation that a peptide corresponding to the site of lamin A cleavage by Mch2␣ also inhibited lamin A cleavage in S͞M extracts strongly suggests that recombinant Mch2␣ and the endogenous lamin protease in S͞M extracts cleave lamin A at the same site. Although these data are consistent with the notion that Mch2␣ is responsible for lamin cleavage in apoptotic cells, we cannot rule out the possibility that other novel CED-3-related IRPs (T.F.-A. & E.S.A., unpublished work) might also cleave the lamins.
Although further study is required to reveal the biological relevance of the inhibition of lamin A cleavage by Zn 2ϩ , it is worth noting that Zn 2ϩ is known to be a modulator of apoptosis in vivo. Zn 2ϩ depletion has been associated with enhanced apoptosis in the small intestine (31) and thymus (32) of rodents as well as with induction of apoptosis in cultured cells (33) (34) (35) (36) . Conversely, Zn 2ϩ supplementation inhibits internucleosomal DNA fragmentation and morphological features of apoptosis in vivo (34, (37) (38) (39) (40) and in vitro (12, 41) . The targets for this suppression of apoptosis by Zn 2ϩ remain unclear, although apoptotic nucleases have been suggested as possible candidates (42, 43) . An alternative hypothesis is that some of the effects of Zn 2ϩ on apoptosis are exerted, at least in part, through a modulation of the actions of IRPs such as Mch2␣. Consistent with this hypothesis, we have observed that lamin cleavage by recombinant Mch2␣ is inhibited by millimolar concentrations of Zn 2ϩ . It has also been reported that ICE activity is inhibited by Zn 2ϩ at concentrations higher than 375 M (44). Conversely, it is worth noting that the effects of Zn 2ϩ on apoptosis are unlikely to be mediated by effects on CPP32, which was relatively insensitive to the cation.
Based on the observation that CPP32 and Mch2␣ can be labeled with the active site titrant YV(bio)KD-aomk (25), we have developed a procedure to directly visualize the spectrum of IRPs that is activated during apoptosis. This procedure labeled at least five distinct polypeptides in S͞M extracts. We termed these prICE [1] [2] [3] [4] [5] . These five labeled polypeptides all correspond to active IRPs, because the labeling is abolished by but not cleavage of purified PARP by cloned human CPP32. Purified PARP (300 ng) (E) and purified recombinant human lamin A (400 ng) (Ⅺ) were incubated with E. coli lysates (30 g) containing CPP32 or Mch2␣, respectively, in the presence of ZnCl2 at the indicated concentrations. The E. coli lysates were previously dialyzed against MDB lacking EGTA for 3 hr at 4°C (12) . After incubation for 15 min (for PARP cleavage) or 120 min (for lamin A cleavage), substrate cleavage was quantitated from immunoblots similar to those shown in Fig. 1 (1996) pretreatment of extracts with YVAD-cmk. The simplest interpretation of these results is that S͞M extracts contain at least five distinct active IRPs. These could be the products of five different genes or certain of the labeled species could be produced by either alternative splicing of a common mRNA transcript or alternative proteolytic processing of a primary translation product. cDNA cloning studies have revealed that Jurkat cells express at least seven different IRP genes (4, 7, 10, 11) and produce at least five alternatively spliced forms of the ICE transcript (10) . Regardless of their origin, our further analysis revealed functional distinctions between several of these enzymes. First, the labeled species show a 100-fold range in apparent affinity for YV(bio)KD-aomk, with prICE 4 being labeled at concentrations as low as 0.1 M and prICE 2 and prICE 3 being labeled only at 100 M. Second, preincubation of S͞M extracts with the PARP cleavage site peptide resulted in a preferential decrease in the labeling of prICE 1 . Thus, among the major prICE species, prICE 1 appears to have a selective affinity for the PARP cleavage site. It is therefore tempting to suggest that prICE 1 might be a PARP protease. In similar experiments, use of the lamin peptide as an inhibitor brought about a selective decrease in the labeling of prICE 5 , This result, together with the results of IRP inhibition with the serpin-like inhibitor CrmA͞ SPI2 suggest that prICE 5 may have a selective affinity for the lamin cleavage sequence (A.T., P-Y. Musy, G.G.P., R. W. Moyer, and W.C.E., unpublished work). The preferred substrates for prICE [2] [3] [4] remain to be determined.
These results show that the YV(bio)KD-aomk reagent can directly label active apoptosis-associated IRPs in cell-free extracts and that the substrate preferences of these labeled IRPs can be analyzed using cleavage site peptides. This methodology should be of significant utility in the future analysis of apoptotic execution in a wide range of cell death events.
Our observations suggest that apoptotic execution in higher eukaryotic cells involves the coordinated action of multiple IRPs, each with a distinctive menu of preferred targets. To the extent that expression of these IRPs differs between various cell types, the cleavage of various substrates and the sensitivity to various inhibitors might also vary. Instead of a single CED-3-related ''death protease'' and a universal death pathway, it is possible that different cell types might use a number of subtly different alternative pathways (45) . Such a mechanism might provide important flexibility to the range of cellular responses to environmental signals.
